News & Events

You are here

See Top 10 CRO article here

Asia-Pacific specialist CRO Novotech has been selected as one of the Top 10 CROs globally by leading industry media magazine Pharma Tech Outlook.

24/07/17

Novotech Update: South Korea to cover standard of care for patients participating in clinical trials

In a recent update, South Korea’s National Health Insurance Program outlined plans to also cover the cost of standard of care (SOC) for patients participating in clinical trials ...

24/07/17

Novotech Update: India streamlines clinical trial approval process and reduces regulatory timelines

While India is home to almost 17% of the world’s population and 20% of its disease burden, it has one of the lowest clinical trial densities in the world; and while this ratio is not unexpected given its population size, India’s clinical trial...

19/07/17

Novotech launches new site management organisation (SMO) business in South Korea

19 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include clinical trial site management organisation (SMO)...

19/07/17

노보텍, 임상시험실시지원기관노보텍SMO 설립

2017 719 호주시드니대한민국서울:  ...

29/06/17

Novotech receives ISO 9001:2015 certification

29 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has received ISO 9001:2015 Quality Management System certification for its corporate headquarters in Sydney, Australia.

...

19/06/17

Novotech signs central lab services agreement with Sonic Clinical Trials

19 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an...

13/06/17

Novotech Update: Five things you need to know about China’s changing clinical trial environment

Novotech Update: New policy reforms in China focus on reducing clinical trial start up times and improving site access 

China currently has one of the largest...

15/04/17

Novotech signs MOU with South Korea’s leading medical center, the Asan Medical Center

15 April 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea’s largest medical institution – The Asan Medical Center’s...

01/03/17

New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials

 

1 March 2017, Sydney, Australia: Frost & Sullivan today released its latest white paper, ‘Asia: Preferred Destination for Clinical Trials’, with Asia Pacific specialist CRO Novotech. Research...

27/01/17

Novotech Update: 8 reasons why China should be your next clinical trial destination

Happy Chinese New Year!
While China has long been a key powerhouse in Asia, its trajectory over the next decade is set to sky rocket. 

Here are 8 top facts you need to know about China’s growing economy and...

Pages